PHGE BiomX Inc

Price (delayed)

$0.8179

Market cap

$8.3M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$35.66

Enterprise value

$7.13M

?
Relative Growth: Rel. Growth: 10
Relative Strength: Rel. Strength: 0
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 0

BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria ...

Highlights
BiomX's debt has plunged by 100% from the previous quarter and by 100% YoY
The equity has shrunk by 104% YoY but it rose by 32% QoQ
PHGE's EPS has dropped by 61% since the previous quarter but it is up by 23% year-on-year
The quick ratio has dropped by 84% year-on-year and by 38% since the previous quarter
BiomX's net income has shrunk by 74% QoQ and by 47% YoY

Key stats

What are the main financial stats of PHGE

PHGE stock price

How has the BiomX stock price performed over time
Intraday
-5.79%
1 week
-47.57%
1 month
9.05%
1 year
-91.61%
YTD
-56.26%
QTD
-78.21%

Financial performance

How have BiomX's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$34.86M
Net income
-$63M
Gross margin
N/A
Net margin
N/A
BiomX's net income has shrunk by 74% QoQ and by 47% YoY
PHGE's operating income is up by 23% YoY and by 16% QoQ

Price vs fundamentals

How does PHGE's price correlate with its fundamentals

Growth

What is BiomX's growth rate over time

Valuation

What is BiomX stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
PHGE's EPS has dropped by 61% since the previous quarter but it is up by 23% year-on-year
The equity has shrunk by 104% YoY but it rose by 32% QoQ

Efficiency

How efficient is BiomX business performance
PHGE's return on invested capital has dropped by 189% since the previous quarter
The ROA has plunged by 175% from the previous quarter

Dividends

What is PHGE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PHGE.

Financial health

How did BiomX financials performed over time
The total assets is 21% smaller than the total liabilities
The total assets has dropped by 93% year-on-year and by 44% since the previous quarter
The quick ratio has dropped by 84% year-on-year and by 38% since the previous quarter
BiomX's debt is 100% more than its equity
The equity has shrunk by 104% YoY but it rose by 32% QoQ
The company's debt to equity has surged by 100% QoQ but it has shrunk by 100% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.